Zinc prevents vaginal candidiasis by inhibiting expression of an inflammatory fungal protein

Elena Roselletti1, Eva Pericolini2, Alexandre Nore1

  • 1Medical Research Council Centre for Medical Mycology at the University of Exeter, University of Exeter, Geoffrey Pope Building Stocker Road, Exeter EX4 4QD, UK.

PubMed

Insights

Vulvovaginal candidiasis (VVC) is often caused by Candida albicans. Researchers found that the Pra1 protein is a key factor in VVC inflammation and developed a zinc-based treatment to prevent reinfection.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Vulvovaginal candidiasis (VVC) affects millions annually, primarily caused by Candida albicans.
  • The precise molecular mechanisms driving VVC immunopathology remain largely unknown.
  • Candida albicans releases Pra1 (pH-regulated antigen) in response to zinc limitation.

Purpose of the Study:

  • To identify the molecular determinant of VVC immunopathology.
  • To explore a potential preventative strategy for VVC disease.

Main Methods:

  • Examined PRA1 gene expression in vaginal infections and correlated it with cytokine levels.
  • Utilized genetic deletion of PRA1 in a mouse model of vaginal inflammation.
  • Assessed the effect of zinc solution application on PRA1 expression and inflammation.
  • Conducted a clinical trial using zinc gel for recurrent VVC prevention.

Main Results:

  • PRA1 gene expression was significantly upregulated during vaginal infections and correlated with proinflammatory cytokines.
  • Deletion of PRA1 prevented vaginal inflammation in mice.
  • Zinc application downregulated PRA1 expression and blocked immunopathology.
  • Zinc gel treatment successfully prevented reinfections in women with recurrent VVC.

Conclusions:

  • Pra1 is a key mediator of symptomatic VVC immunopathology.
  • Targeting Pra1 with zinc offers a promising preventative strategy for VVC.
  • This research opens avenues for developing novel VVC preventative measures.

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
Defense Mechanism Against Infection01:26

Defense Mechanism Against Infection

Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
6.5K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K